Oncotarget Journal
@OncotargetJrnl
Followers
81
Following
2K
Media
1
Statuses
477
For the latest news and updates from Oncotarget, please follow us @Oncotarget.
Orchard Park, NY
Joined December 2019
📈 #TrendingWithImpact: This #review was #published in Volume 16, titled "Mechanism of anticancer action of bifidobacterium: Insights from gut microbiota." #PressRelease ⬇️ https://t.co/sDNSgPVoWi
#cancer #oncology #bifidobacterium #anticancer #research #oa #press #publishing
oncotarget.com
“The anticancer properties of bifidobacterium may also stem from its ability to detoxify carcinogens and transform dietary elements.”
0
1
0
🔆 #PaperSpotlight: This #research perspective was #published in Volume 16, titled "A personal perspective of patient-centred clinical trials." #PressRelease ⬇️ https://t.co/GRRtnkx2XT
#cancer #oncology #clinicaltrial #drugdevelopment #oa #publishing #meded #press #perspective
oncotarget.com
“By embracing transparency, inclusivity, and patient advocacy, we can transform clinical trials into a true partnership between medical research and the individuals it seeks to serve.”
0
1
0
📈 #TrendingWithImpact: This #research paper was #published in Volume 16, titled "LRIG1-3 in gliomas: LRIG1 protein expression decreased in higher grade gliomas." #PressRelease ⬇️ https://t.co/DMgfDdnmdw
#cancer #glioma #glioblastoma #oncology #oa #publishing #meded #press
oncotarget.com
“Our results reinforce suggestions that LRIG1-3 could function as diagnostic markers and therapeutic targets in the treatment of gliomas.”
0
1
0
🔆 #PaperSpotlight: "Anti-DNA virus agent cidofovir - loaded green synthesized cerium oxide nanoparticles (Nanoceria): Nucleic acids (DNA and RNA) binding affinity and cytotoxicity effects" #PressRelease ⬇️ https://t.co/1JYuCwKqYA
#cancer #oncology #research #press #publishing
oncotarget.com
“This environmentally friendly technique represents a novel approach to nanoparticle fabrication, emphasizing sustainability in nanotechnology.”
0
1
0
🔆 #PaperSpotlight: "Widespread folate receptor expression in pediatric and adolescent solid tumors - opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine" #PressRelease ⬇️ https://t.co/XE9p8dpkO0
#cancer #research #oncology #pafolacianine
oncotarget.com
“This pre-clinical study demonstrates a broad potential application for pafolacianine in pediatric solid tumor resection.”
0
1
0
📈 #TrendingWithImpact: This #research paper was #published in Volume 16, titled "Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields." #PressRelease ⬇️ https://t.co/R4tj1efWTZ
#cancer #glioblastoma #oa #publishing #press
oncotarget.com
“Intrabuccal administration of amplitude-modulated 27.12 MHz radiofrequency electromagnetic fields (AM RF EMF) resulting in the systemic delivery of low and safe levels of AM RF EMF has shown...
0
1
0
📈 #TrendingWithImpact: "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and..." #PressRelease ⬇️ https://t.co/hkO8AA9pfw
#research
oncotarget.com
“ACTM-838 showed durable anti-tumor efficacy in multiple murine tumor models and synergized with anti-PD1 therapy in combination.”
0
1
0
Oncotarget Editor-in-Chief @weldeiry to chair the WIN Symposium at the Advancing Precision Medicine Annual Conference, October 3–4, 2025 in Philadelphia. #PressRelease ⬇️ https://t.co/tACdGEMYF0
#Oncology #CancerResearch #PrecisionMedicine #Conference #Press
oncotarget.com
The WIN Symposium featured as the Oncology Track at the APM Annual Conference 2025 unites global leaders in oncology, translational science, and precision medicine.
0
3
3
📈 #TrendingWithImpact: "Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma" #PressRelease ⬇️ https://t.co/6a02Dwzeah
#cancer #ovariancancer #oa
oncotarget.com
“These results highlight potential mechanisms by which loss of p53 function contributes to an immunosuppressive microenvironment in HGSC, and provide insight into the role of ovarian and peritoneal...
0
1
0
📈 #TrendingWithImpact: This #research paper was #published in Volume 16, titled "In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma." #PressRelease ⬇️ https://t.co/OVEZ8MDZ9f
#cancer #oncology #openaccess #publishing #peerreviewed #journal #press
oncotarget.com
“Together, these findings confirm that proteostasis inhibition can slow RMS growth and suggest that targeting compensatory network components might yield synergistic outcomes.”
1
1
0
📈 #TrendingWithImpact: This #research paper was #published in Volume 16, titled "The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivo." #PressRelease ⬇️ https://t.co/zU3M6PVOuR
#cancer #oncology #tumors #oa #publishing #press
oncotarget.com
“We determined in GI tumor cells that regorafenib interacted with aramchol to promote tumor cell killing.”
0
1
0
🔆 #PaperSpotlight: "Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay" #PressRelease ⬇️ https://t.co/Ez32CMHnTe
#research #precisiononcology #press #oa
oncotarget.com
“Accordingly, MI Cancer Seek represents a safe and effective comprehensive molecular test option supporting biomarker-directed care for oncology patients.”
1
1
0
📈 #TrendingWithImpact: "PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesion." #PressRelease ⬇️ https://t.co/aRZf3d9TUZ
#cancer #breastcancer #press #research
oncotarget.com
“The ability of PCAIs to mitigate various cancer hallmarks in the various cancer cell lines has been well established.”
0
1
0
🔆 #PaperSpotlight: Thi #researchpaper was recently #published in Volume 16: "Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer." #PressRelease ⬇️ https://t.co/gwGVULDI0n
#cancer #prostatecancer #research #oa
0
1
0
📈 #TrendingWithImpact: This #research paper was #published in Volume 16, entitled "Comprehensive genomic profiling of over 10,000 advanced solid tumors." #PressRelease ⬇️ https://t.co/qDqj1chpKM
#cancer #oncology #tumors #oa #peerreview #journal #publishing #meded #press
oncotarget.com
“The broad capabilities of the OncoExTra assay detected therapeutically actionable and other clinically relevant genomic events that can inform clinical decision-making for patients with advanced...
0
1
0
🔆 #PaperSpotlight: "Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: A case report." #PressRelease ⬇️ https://t.co/aQK2FMU0RX
#cancer #pancreaticcancer #oa #press
oncotarget.com
“Therapeutic modalities that explore CTC removal via blood filtration may potentially have promising clinical benefits.”
0
1
0
📈 #TrendingWithImpact: This #researchpaper was #published in Volume 16, titled “Statins exhibit anti-tumor potential by modulating Wnt/β-catenin signaling in colorectal cancer.” #PressRelease ⬇️ https://t.co/ZQDvto1o5Z
#cancer #press #colorectalcancer #statins #research #oa
oncotarget.com
“Our findings provide direct evidence that statins selectively modulate key components of the Wnt/β-catenin signaling pathway, a major driver of adenoma formation, including members of the special...
0
1
0
🔆 #PaperSpotlight This new #editorial was #published in Volume 16, titled "microRNAs in soft tissue sarcoma: State of the art and barriers to translation." #PressRelease ⬇️ https://t.co/NzyitPsxSg
#cancer #liposarcoma #microRNA #biomarkers #press #oa #publishing #openaccess
oncotarget.com
“[...] miRNAs are pivotal in regulating gene expression in STS and have been recognized as crucial biomarkers for the diagnosis, prognosis, and therapeutic decision-making in patients.”
0
1
0
📈 #TrendingWithImpact: This #research paper was #published in Volume 16, entitled "A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment." #PressRelease ⬇️ https://t.co/4sv5rDHbww
#cancer #press
oncotarget.com
“Taken together, our studies suggest that 2B010 represents an anti-CD25 mAb with unique properties in that it deleted Treg from an inflammatory environment (GVHD) as well as from the TME.”
0
1
0
🔆 #PaperSpotlight: This #research paper was #published in Volume 16, entitled "Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer." #PressRelease ⬇️ https://t.co/CWSAxbg1jV
#cancer #prostatecancer #hypoxia #press #oa #publishing
oncotarget.com
“[...] manipulating LD dynamics represents a promising strategy to overcome hypoxia-induced resistance to ferroptosis and improve the success of PCa treatment.”
0
2
3